At a time when people are more aware of and engaged in their health care than ever before, genetic risk testing can provide helpful information about an individual's predisposition for certain diseases and conditions. These tests can prompt consumers to be more engaged in pursuing the benefits of healthy lifestyle choices and more aware of their health risks. Consumers are increasingly embracing genetic health risk (GHR) testing to better understand their individual risk for developing diseases. This engagement prompts some people to make more informed lifestyle choices.

Over half of people in 10 states who died of opioid overdoses during the second half of 2016 tested positive for fentanyl, according to new data published today in CDC's Morbidity and Mortality Weekly Report (MMWR) Early Release.

The Mayo Clinic Board of Trustees re-elected Samuel Di Piazza as its chair at its quarterly meeting today. He will serve another four-year term.

At least 76 confirmed and suspected cases of a bacterial infection called leptospirosis have been reported in Puerto Rico since Hurricane Maria swept through the island in September. Dr. Pritish Tosh, a Mayo Clinic infectious diseases specialist, says, "Leptospirosis is a serious infection that people can often get when they are exposed to contaminated water."

Twelve awards totaling $9 million in Fiscal Year 2017 will launch a National Institutes of Health Data Commons Pilot Phase. A data commons is a shared virtual space where scientists can work with the digital objects of biomedical research, such as data and analytical tools. The NIH Data Commons will be implemented in a four-year pilot phase to explore the feasibility and best practices for making digital objects available through collaborative platforms. This will be done on public clouds, which are virtual spaces where service providers make resources, such as applications and storage, available over the internet.

As scientists develop powerful neurotechnologies to monitor and regulate brain activity, ethical questions arise about how these new tools should be incorporated into medical research and clinical practice. To inform this discussion, the National Institutes of Health has awarded grants to five teams of experts who will study the neuroethical issues surrounding the use of deep brain stimulation in neuropsychiatric and movement disorders and appropriate consent for brain research.